Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: FRANKLIN TEMPLETON INC
Alpha Vantage · StreetInsider · · AI-summarised by FinFlash
Franklin Templeton, Inc. has filed an amended Schedule 13G/A for Contineum Therapeutics, Inc., reporting beneficial ownership of 1,704,550 Class A Common Stock shares, representing 5.2% of the class. The filing also names Charles B. Johnson, Rupert H. Johnson, Jr., and Franklin Advisers, Inc. as reporting persons.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.